QQ客服 官方微博 反馈留言

	Combined inhibition of notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect
	Li M.; Chen F.; Clifton N.; Sullivan D.M.; Dalton W.S.; Gabrilovich D.I.; Nefedova Y.
刊名	Molecular Cancer Therapeutics
	2010
卷号	9期号:12页码:3200-3209
DOI	10.1158/1535-7163.MCT-10-0372
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5482152
专题	山东大学
作者单位	1.H. Lee Moffitt Cancer Center and Research Institute, MRC 2067H, 12902 Magnolia Dr, Tampa, FL, United States 2.H. Lee Moffitt Cancer C
推荐引用方式 GB/T 7714	Li M.,Chen F.,Clifton N.,et al. Combined inhibition of notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect[J]. Molecular Cancer Therapeutics,2010,9(12):3200-3209.
APA	Li M..,Chen F..,Clifton N..,Sullivan D.M..,Dalton W.S..,...&Nefedova Y..(2010).Combined inhibition of notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect.Molecular Cancer Therapeutics,9(12),3200-3209.
MLA	Li M.,et al."Combined inhibition of notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect".Molecular Cancer Therapeutics 9.12(2010):3200-3209.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。